Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation

Transplantation

Volumn 87, Issue 6, 2009, Pages 795-802

  Opelz, Gerhard ^a   Döhler, Bernd ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Azathioprine; Cyclosporine A; Graft survival; Immunosuppression; Kidney transplantation; MMF; MPA; Mycophenolic acid; Tacrolimus

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE ACID PROTEIN; MYCOPHENOLIC ACID; TACROLIMUS; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER KIDNEY; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG CHOICE; FEMALE; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KAPLAN MEIER METHOD; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; REGRESSION ANALYSIS; REOPERATION; STATISTICS;

ADRENAL CORTEX HORMONES; ADULT; AZATHIOPRINE; CYCLOSPORINE; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS; REOPERATION; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 65549141734     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318199c1c7     Document Type: Article

References (26)

1. Meier-Kriesche HU, Li S, Gruessner RW, et al. Immunosuppression: Evolution in practice and trends, 1994-2004. Am J Transplant 2006; 6: 1111.
2. Webster AC, Woodroffe RC, Taylor RS, et al. Tacrolimus versus cyclosporine as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data. BMJ 2005; 331: 810.
3. Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506.
4. Silva HT Jr, Yang HC, Abouljoud M, et al. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/ MMF in de novo kidney transplant recipients. Am J Transplant 2007; 7: 595.
5. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
6. Halloran P, Mathew T, Tomlanovich S, et al. Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 1997; 63: 39.
7. Remuzzi G, Lesti M, Gotti E, et al. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): A randomised trial. Lancet 2004; 364: 503.
8. Remuzzi G, Cravedi P, Costantini M, et al. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: The MYSS follow-up randomized, controlled clinical trial. J Am Soc Nephrol 2007; 18: 1973.
9. Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378.
10. Mcdonald S, Russ G, Campbell S, et al. Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome. Am J Transplant 2007; 7: 1201.
11. Opelz G, Döhler B. Influence of time of rejection on long-term graft survival in renal transplantation. Transplantation 2008; 85: 661.
12. SijpkensYW, Doxiadis II, Mallat MJ, et al. Early versus late acute rejection episodes in renal transplantation. Transplantation 2003; 75: 204.
13. Goldfarb-Rumyantzev AS, Smith L, Shihab FS, et al. Role of maintenance immunosuppressive regimen in kidney transplant outcome. Clin J Am Soc Nephrol 2006; 1: 563.
14. Kaplan B, Schold J, Meier-Kriesche H-U. Long-term graft survival with Neoral and tacrolimus: A paired kidney analysis. J Am Soc Nephrol 2003; 14: 2980.
15. Woodward RS, Kutinova A, Schnitzler MA, et al. Renal graft survival and calcineurin inhibitor. Transplantation 2005; 80: 629.
16. Irish W, Sherrill B, Brennan DC, et al. Three year posttransplant survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple drug regimen. Transplantation 2003; 76: 1686.
17. Bunnapradist S, Daswani A, Takemoto S. Graft survival following living-donor renal transplantation: A comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids. Transplantation 2003; 76: 10.
18. Ojo AO, Meier-Kriesche H-U, Hanson JA, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000; 69: 2405.
19. Meier-Kriesche HU, Ojo AO, Leichtman AB, et al. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival. Transplantation 2001; 71: 398.
20. Collaborative Transplant Study. Available at: www.http://ctstransplant. org. Accessed April 2008.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
22. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34: 187.
23. Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004; 4: 1.
24. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
25. Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among US wait-listed and transplant renal allograft recipients. Am J Transplant 2003; 3: 590.
26. Bates WD, Davies DR, Welsh K, et al. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome. Nephrol Dial Transplant 1999; 14: 2364.